Notably, RT-qPCR analysis revealed that ablation of ADAM17 did not significantly reverse the improvement of CX3CL1 expression in VBMECs co-cultured with NSCLC cells (Figure 6G). This evidence concerns the gene ADAM17 and non-small cell lung carcinoma.